Affiliation:
1. Orthopaedic Outcomes Department Musgrave Park Hospital, Stockman’s Lane, Belfast BT9 7JB, Northern Ireland.
Abstract
We studied 4253 patients undergoing primary joint replacement between November 2002 and November 2007, of whom 4060 received aspirin only as chemical prophylaxis; 46 were mistakenly given low molecular weight heparin initially, which was stopped and changed to aspirin; 136 received no chemoprophylaxis and 11 patients received warfarin because of a previous history of pulmonary embolism. We identified the rate of clinical thromboembolism before and after discharge, and the mortality from pulmonary embolism at 90 days. The overall death rate was 0.31% (13 of 4253) and the rate of fatal pulmonary embolism was 0.07% (3 of 4253). Our data suggest that fatal pulmonary embolism is not common following elective primary joint replacement, and with modern surgical practice elective hip and knee replacement should no longer be considered high-risk procedures.
Publisher
British Editorial Society of Bone & Joint Surgery
Subject
Orthopedics and Sports Medicine,Surgery
Reference24 articles.
1. No authors listed. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE clinical guideline 46 2007.
2. NICE work
3. THE CONTRAST BETWEEN VENOGRAPHIC AND CLINICAL ENDPOINTS IN TRIALS OF THROMBOPROPHYLAXIS IN HIP REPLACEMENT
4. No authors listed, House of Commons Health Committee. The prevention of venous thromboembolism in hospitalised patients. Second report of session 2004-05. HC99 published 8th March 2005 by authorisation of the House of Commons London: The Stationary Office Ltd.
5. No authors listed. National Joint Registry 4th annual report. www.njrcentre.org.uk (date last accessed 20 September 2008).
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献